US2017027740A1PendingUtilityA1

Contraceptive devices and methods

50
Assignee: BAYER HEALTHCARE LLCPriority: Oct 23, 2009Filed: Aug 22, 2016Published: Feb 2, 2017
Est. expiryOct 23, 2029(~3.3 yrs left)· nominal 20-yr term from priority
A61F 6/225A61B 17/12022A61B 17/12186A61F 6/22A61B 8/0841A61B 17/12172A61B 17/1215A61F 6/24A61B 17/1219A61B 17/12099A61B 1/303A61M 25/00A61B 17/12145A61B 2017/4233A61M 25/0067A61B 6/12
50
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

Contraceptive devices that provide substantially immediate and permanent sterilization are described herein. Systems and methods for transcervically delivering the contraceptive devices are also described herein. The contraceptive device may include an expandable implant. The implant includes hydrogel to provide substantially immediate sterilization, and tissue in-growth fibers to provide permanent sterilization. As an alternative or in combination to hydrogel, the implant may include copper or cupric ions to provide substantially immediate sterilization. The implant may also include hydrogel to improve trackability of the implant through an ovarian pathway.

Claims

exact text as granted — not AI-modified
1 . A system for delivering an occlusion device to a body lumen comprising:
 a catheter having a distal end and a proximal end;   an occlusion device releasably coupled with the catheter, the occlusion device comprising hydrogel; and   a hydrophilic material at a distal end of the catheter, wherein the distal end of the occlusion device extends beyond the distal end of the catheter while the hydrophilic material protects the hydrogel from swelling upon exposure of the distal end of the catheter to a physiological environment, and the hydrophilic material is pierceable by the occlusion device to deliver the occlusion device through the distal end of the catheter.   
     
     
         2 - 21 . (canceled)

Cited by (0)

No later patents cite this yet.

References (0)

No backward citations on record.